Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Precigen Inc (NASDAQ: PGEN) closed the day trading at $3.64 up 13.40% from the previous closing price of $3.21. In other words, the price has increased by $13.40 from its previous closing price. On the day, 21.64 million shares were traded. PGEN stock price reached its highest trading level at $3.89 during the session, while it also had its lowest trading level at $3.16.
Ratios:
For a better understanding of PGEN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 2.71.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 1084621696 and an Enterprise Value of 1060904448. For the stock, the TTM Price-to-Sale (P/S) ratio is 249.91. Its current Enterprise Value per Revenue stands at 244.448 whereas that against EBITDA is -11.549.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.71, which has changed by 2.137931 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $3.49, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 100.40%, while the 200-Day Moving Average is calculated to be 152.41%.
Shares Statistics:
Over the past 3-months, PGEN traded about 5.77M shares per day on average, while over the past 10 days, PGEN traded about 25722040 shares per day. A total of 297.85M shares are outstanding, with a floating share count of 147.64M. Insiders hold about 50.45% of the company’s shares, while institutions hold 27.55% stake in the company. Shares short for PGEN as of 1753920000 were 28833129 with a Short Ratio of 5.00, compared to 1751241600 on 29034954. Therefore, it implies a Short% of Shares Outstanding of 28833129 and a Short% of Float of 16.950001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
At present, 1.0 analysts are actively evaluating the performance of Precigen Inc (PGEN) in the stock market.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.42 and -$0.42 for the fiscal current year, implying an average EPS of -$0.42. EPS for the following year is $0.07, with 1.0 analysts recommending between $0.07 and $0.07.
Revenue Estimates
For the next quarter, 3 analysts are estimating revenue of $14.38M. There is a high estimate of $15.34M for the next quarter, whereas the lowest estimate is $13.6M.
A total of 3 analysts have provided revenue estimates for PGEN’s current fiscal year. The highest revenue estimate was $17.53M, while the lowest revenue estimate was $17.4M, resulting in an average revenue estimate of $17.48M. In the same quarter a year ago, actual revenue was $3.92MBased on 4 analysts’ estimates, the company’s revenue will be $108.91M in the next fiscal year. The high estimate is $158.5M and the low estimate is $64M.
